Global Risk Capital Divests Velan’s Asbestos Liabilities; Framatome to Buy Velan’s French Subsidiaries

January 14, 2025

Velan Inc. entered into a definitive agreement with an affiliate of Global Risk Capital to permanently divest its asbestos-related liabilities by selling Velan Valve Corp. Global Risk Capital will capitalize the U.S. subsidiary with US$143 million (plus US$7 million from the Buyer), removing asbestos liabilities from Velan’s balance sheet. Separately, Velan Valves Limited signed an MoU to sell its French subsidiaries (Segault SAS and Velan S.A.S.) to Framatome SAS for US$175.2 million (€170 million), with total consideration to Velan of US$198.4 million (€192.5 million) including transfer of an intercompany loan; definitive agreement is subject to shareholder approval.

Buyers
Global Risk Capital (affiliate), Framatome SAS
Targets
Velan Valve Corp., Segault SAS, Velan S.A.S., Velan Valves Limited (seller of French subsidiaries, wholly-owned subsidiary)
Sellers
Velan Inc.
Location
Quebec, Canada
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.